VN
Vanda Pharma
VNDA·NASDAQWashington DCFounded 2002250 employees
Small CapbiotechPublicCNS
Platform: Tradipitant GI
Market Cap
$0.4B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (VNDA)
Loading VNDA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| VND-7068 | VND-7068 | Phase 2 | 2 | MALT1 | Gastric CaPBC | ||
| Semaglumide | VND-8570 | Approved | 3 | SGLT2 | AngelmanCrohn's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)